Bloomberg Businessweek debrief. Jason Kelly /

The hot new buzzword in tech is synthetic biology. Its main purveyor is a startup with hundreds of millions in investment and a valuation of [dollar]4.2 billion. Gingko Bioworks CEO Jason Kelly spoke with Bloomberg Businessweek Editor Joel Weber about how his company plans to change the world, from...

Full description

Bibliographic Details
Other Authors:	Weber, Joel (Interviewer)
Format:	Video
Language:	English
Language Notes:	In English.
Published:	New York, NY : Bloomberg, 2020.
Series:	Academic Video Online
Subjects:	Gingko Bioworks (Firm) Synthetic biology. Entrepreneurship. New business enterprises > Management. New business enterprises > Finance. Businesspeople > United States > Interviews. Biologie synthétique. Entrepreneuriat. Nouvelles entreprises > Gestion. Gens d'affaires > États-Unis > Entretiens. Businesspeople Entrepreneurship New business enterprises > Finance New business enterprises > Management Synthetic biology United States interviews. Interviews Interviews.
Online Access:	Connect to this streaming video (Alexander Street Press)

Description
Summary:	The hot new buzzword in tech is synthetic biology. Its main purveyor is a startup with hundreds of millions in investment and a valuation of [dollar]4.2 billion. Gingko Bioworks CEO Jason Kelly spoke with Bloomberg Businessweek Editor Joel Weber about how his company plans to change the world, from genes on up.
Item Description:	Title from resource description page (viewed April 18, 2022).
Physical Description:	1 online resource (24 minutes)
Playing Time:	00:23:51